The particulars: an HPLC purity test · a five-person group buy.
This is a planning question. I know what my options are; I do not know how to weigh them.
What I want is the minimum viable version, which I suspect is smaller than what I would design.
What does a sensible plan look like, and what are the decision points?
The short version: real savings on carriage and unit price, real risks in custody, splitting and the legal position of whoever receives it.
The real saving is in carriage and in unit price breaks, not in the compound itself. Carriage on a single larger consignment is typically a fraction of the sum of individual shipments, and that is where most of the arithmetic comes from.
| Step | Value | Note |
|---|---|---|
| Vial price, 10 mg nominal | £34.00 | As advertised |
| Nominal cost per mg | £3.40 | 34 ÷ 10 |
| Measured content | 9.2 mg | Independent content assay |
| Cost per actual mg | £3.70 | 34 ÷ 9.2 |
| Dead-space loss, 20 draws | 4 % | 80 µL of a 2 mL fill |
| Cost per delivered mg | £3.85 | 3.70 ÷ 0.96 |
| First vial, with £110 assay | £14.85 | Testing dominates a single vial |
Keep a written record: who contributed, what was ordered, which lot arrived, how many vials each person received and when. It resolves disputes and it is the only documentation that will exist.
Importer-of-record status attaches to the receiving party in most customs regimes and is not divisible among contributors.
The caveat is legal rather than analytical: onward supply is treated differently from personal importation in many jurisdictions and the difference is not a technicality.
Whoever receives it is the importer. Make sure that person knows.
edited 1 Aug 2024 by j_wierzbicki — reworded for clarity after a comment
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsThe relevant point is that whoever receives the consignment is the importer, with whatever that means in their jurisdiction.
Ordering a single lot for the whole group is the analytical advantage: one independent submission then characterises everyone's material, which spreads the cost of testing across the participants.
It helps to be literal here: splitting sealed vials preserves the manufacturer's container closure and the lot traceability. Splitting anything that has been opened, reconstituted or repackaged breaks both and no certificate follows the material after that point.
Container closure integrity is what makes a lot-specific certificate meaningful for a specific vial; breaking it severs the link between document and material.
One lot for the group means one submission covers everybody. That is the real advantage.
Answer first: the economics work and the counterparty risk is the whole problem, because a group buy concentrates money and material in one person's hands.
Whoever receives the consignment is the importer of record in most jurisdictions, regardless of who paid. That is a legal position rather than an administrative one and it does not divide among contributors.
A first group order should be small for the same reason a first individual order should be, and the argument is stronger rather than weaker when several people are exposed.
There is no recourse mechanism in an informal arrangement. That is the risk, and it cannot be structured away entirely.
Split sealed vials only. Anything else breaks the certificate and the closure together.
A single lot across the group is the one genuine analytical advantage, because everyone's vial is then covered by the same test.
Custody is the risk. One person holds the money before the order and the material after it, and there is no mechanism to compel anything if it goes wrong.
Splitting opened or reconstituted material is a manufacturing step performed outside any controlled environment.
Write down who paid what and who received what, before it ships.
Document who paid what and who received what, in writing, before anything ships.
Onward distribution — even at cost, even among people who paid — may be a different legal act from personal importation in many jurisdictions. It is worth understanding the local position rather than assuming.
Start small even with several people. Especially with several people.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.